C4 Therapeutics Ratios (2019-2025) | CCCC

Ratios Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin -176.06%-123.27%-177.22%-113.35%-260.47%-265.30%-282.40%-230.86%-290.39%-77.99%-413.12%-194.29%-473.17%-960.48%-925.25%-1,348.42%-235.13%-1,057.25%-933.23%-147.56%-160.57%-665.29%-363.66%-402.60%-286.43%
EBIT Margin -186.45%-127.90%-181.02%-112.30%-217.23%-228.79%-276.18%-226.11%-285.34%-75.98%-409.84%-197.95%-481.02%-1,341.73%-963.77%-1,410.21%-251.16%-1,147.72%-1,060.18%-178.59%-183.86%-728.39%-402.93%-440.99%-306.43%
EBITDA Margin -188.09%-122.05%-174.77%-111.63%-258.38%-263.74%-283.84%-230.60%-291.40%-81.07%-450.68%-204.88%-485.43%-1,258.34%-880.90%-1,322.30%-236.33%-1,041.92%-941.56%-148.06%-154.74%-675.58%-363.80%-403.73%-285.39%
Operating Margin -186.45%-127.90%-181.02%-112.30%-217.23%-228.79%-276.18%-226.11%-285.34%-75.98%-409.84%-197.95%-481.02%-1,341.73%-963.77%-1,410.21%-251.16%-1,147.72%-1,060.18%-178.59%-183.86%-728.39%-402.93%-440.99%-306.43%
Net Margin -188.18%-122.10%-205.74%-141.69%-320.20%-138.37%-282.40%-230.86%-290.39%-77.99%-413.12%-194.29%-473.17%-960.48%-925.25%-1,348.42%-244.19%-1,065.75%-933.23%-147.56%-160.57%-667.82%-363.66%-402.60%-286.43%
FCF Margin -124.63%-247.21%-149.79%-173.79%-264.88%-345.49%-188.61%-215.98%-128.40%-349.73%-182.83%-425.76%-1,072.81%-896.89%-726.69%-282.76%-741.06%-596.18%-43.07%-157.01%-346.30%-459.86%-186.55%-280.58%
Efficiency
Assets Average 314.63M387.07M451.21M518.17M507.34M511.12M503.98M476.96M446.14M413.44M385.52M354.01M354.73M387.41M389.73M378.58M362.83M334.56M308.03M281.01M
Equity Average -107.32M-118.25M-129.80M-145.49M62.43M272.25M340.07M407.60M394.19M377.07M354.56M331.39M303.71M275.85M248.09M224.87M231.07M252.20M252.67M244.86M229.32M205.56M184.60M164.24M
Invested Capital -102.67M-111.96M-124.53M-135.06M-146.22M280.79M263.70M416.43M398.78M389.61M365.28M355.71M329.48M300.72M274.22M244.04M216.02M246.11M258.28M247.06M242.66M215.99M195.14M174.06M154.41M
Asset Utilization Ratio 0.110.090.080.070.090.090.100.100.070.070.040.060.060.050.080.090.100.120.110.11
Leverage & Solvency
Debt to Equity -0.060.040.040.020.030.030.030.030.040.040.040.04
Debt Ratio 0.040.030.030.020.020.020.020.020.020.030.030.03
Equity Ratio -0.95-0.680.700.710.790.790.770.710.700.690.670.660.620.650.650.650.650.650.620.610.590.58
Valuation
Enterprise Value -100.97M-90.55M-73.86M-107.65M-199.41M865.57M1,281.51M1,168.60M1,762.87M1,256.47M891.23M60.15M115.32M12.69M-116.31M-132.36M-125.07M24.76M302.28M53.78M139.58M9.22M-101.50M-113.01M-33.88M
Market Capitalization 1,425.57M1,594.99M1,634.51M2,164.94M1,565.74M1,182.40M367.93M428.97M288.85M154.02M134.93M91.49M278.44M560.47M317.88M395.23M254.12M113.58M101.54M158.00M
Return Ratios
Return on Sales -1.42%-1.65%-2.00%-2.23%-2.57%-2.65%-1.83%-2.05%-1.97%-2.20%-3.79%-4.45%-8.11%-6.15%-6.38%-6.29%-3.67%-3.13%-2.96%-2.60%-3.26%-3.96%
Return on Capital Employed -0.22%-0.20%-0.20%-0.18%-0.18%-0.20%-0.21%-0.25%-0.32%-0.36%-0.43%-0.43%-0.45%-0.41%-0.35%-0.36%-0.38%-0.40%-0.47%-0.53%
Return on Invested Capital 0.37%-0.89%
Return on Assets -0.21%-0.19%-0.19%-0.17%-0.17%-0.18%-0.20%-0.22%-0.26%-0.29%-0.34%-0.35%-0.37%-0.33%-0.28%-0.28%-0.29%-0.31%-0.36%-0.42%
Return on Equity 0.33%0.38%-1.06%-0.28%-0.26%-0.22%-0.21%-0.25%-0.28%-0.32%-0.39%-0.44%-0.52%-0.56%-0.57%-0.50%-0.43%-0.43%-0.46%-0.50%-0.60%-0.73%